CME Group(US:CME) Prnewswireยท2024-10-23 11:00Core Insights - CME Group reported record financial results for Q3 2024, achieving revenue of $1.6 billion and operating income of $1.0 billion, with net income at $913 million and diluted earnings per share at $2.50 [1][2][8] - The company experienced a 28% increase in financial product volumes, driven by a 36% rise in interest rates, resulting in a record average daily volume (ADV) of 14.9 million contracts [1][2] - CME Group's ADV reached a record 28.3 million contracts in Q3 2024, with significant growth in non-U.S. ADV, particularly in EMEA (up 30%) and Asia (up 28%) [1][2] Financial Performance - Total revenues for Q3 2024 were $1.584 billion, compared to $1.338 billion in Q3 2023, marking a year-over-year increase [8] - Clearing and transaction fees revenue totaled $1.297 billion, while market data revenue was $178 million for the same period [2][8] - Adjusted net income for Q3 2024 was $977 million, with adjusted diluted earnings per share at $2.68 [1][12] Volume and Market Activity - CME Group's financial product volumes rose significantly, with SOFR futures increasing by 35% to a record ADV of 4.1 million contracts and Treasuries growing by 31% to a record ADV of 8.4 million contracts [1][2] - Commodities volume increased by 20%, and options volume rose by 27% in Q3 2024 [1][2] - The company has seen consistent volume and open interest growth across all asset classes for two consecutive quarters [1][2] Balance Sheet and Cash Flow - As of September 30, 2024, CME Group had approximately $2.6 billion in cash and $3.4 billion in debt, with dividends paid during the quarter totaling approximately $419 million [2][7] - The company has returned approximately $25.6 billion to shareholders in dividends since implementing its variable dividend policy in early 2012 [2]